APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025188 pages

Choose your research edition.

Industry ResearchDual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A include Carna Biosciences Inc, Felicitex Therapeutics, ManRos Therapeutics, NeuroNascent Inc and Pharmasum Therapeutics AS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market size, projected growth trends, production technologies, key applications, and end-use industries.

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Company

Carna Biosciences Inc

Felicitex Therapeutics

ManRos Therapeutics

NeuroNascent Inc

Pharmasum Therapeutics AS

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Type

PST-900

NNI-351

FX-9847

Others

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Application

Pancreatic Cancer

Down Syndrome

Colon Cancer

Lung Cancer

Others

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Trends Table 2. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Drivers Table 3. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Opportunities and Challenges Table 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Restraints Table 5. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Manufacturers Table 9. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Manufacturers, Product Type & Application Table 13. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PST-900 Table 17. Major Manufacturers of NNI-351 Table 18. Major Manufacturers of FX-9847 Table 19. Major Manufacturers of Others Table 20. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021-2026) & (K Units) Table 22. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2027-2032) & (K Units) Table 23. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2021-2026) Table 24. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2027-2032) Table 25. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2021-2026) & (K Units) Table 27. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2027-2032) & (K Units) Table 28. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2021-2026) Table 29. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pancreatic Cancer Table 31. Major Manufacturers of Down Syndrome Table 32. Major Manufacturers of Colon Cancer Table 33. Major Manufacturers of Lung Cancer Table 34. Major Manufacturers of Others Table 35. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021-2026) & (K Units) Table 37. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2027-2032) & (K Units) Table 38. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2021-2026) Table 39. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2027-2032) Table 40. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2021-2026) & (K Units) Table 42. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2027-2032) & (K Units) Table 43. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2021-2026) Table 44. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2027-2032) Table 45. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2021-2026) & (K Units) Table 47. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Region (2021-2026) Table 48. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 52. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 53. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 55. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 62. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2021-2026) Table 66. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2027-2032) Table 67. Carna Biosciences Inc Company Information Table 68. Carna Biosciences Inc Business Overview Table 69. Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 71. Carna Biosciences Inc Recent Development Table 72. Felicitex Therapeutics Company Information Table 73. Felicitex Therapeutics Business Overview Table 74. Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 76. Felicitex Therapeutics Recent Development Table 77. ManRos Therapeutics Company Information Table 78. ManRos Therapeutics Business Overview Table 79. ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 81. ManRos Therapeutics Recent Development Table 82. NeuroNascent Inc Company Information Table 83. NeuroNascent Inc Business Overview Table 84. NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 86. NeuroNascent Inc Recent Development Table 87. Pharmasum Therapeutics AS Company Information Table 88. Pharmasum Therapeutics AS Business Overview Table 89. Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 91. Pharmasum Therapeutics AS Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Distributors List Table 95. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Image Figure 2. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size (2021-2032) & (US$ Million) Figure 4. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (2021-2032) & (K Units) Figure 5. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PST-900 Image Figure 9. NNI-351 Image Figure 10. FX-9847 Image Figure 11. Others Image Figure 12. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2021-2032) Figure 15. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2021-2032) Figure 18. Pancreatic Cancer Image Figure 19. Down Syndrome Image Figure 20. Colon Cancer Image Figure 21. Lung Cancer Image Figure 22. Others Image Figure 23. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2021-2032) Figure 26. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2021-2032) Figure 29. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 31. U.S. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 36. Germany Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 43. China Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 51. Brazil Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032) & (US$ Million) Figure 62. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032) & (US$ Million) Figure 64. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • PST-900
  • NNI-351
  • FX-9847
  • Others
Applications
  • Pancreatic Cancer
  • Down Syndrome
  • Colon Cancer
  • Lung Cancer
  • Others
Companies covered
  • Carna Biosciences Inc
  • Felicitex Therapeutics
  • ManRos Therapeutics
  • NeuroNascent Inc
  • Pharmasum Therapeutics AS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Dynamics
  1. 2.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Trends
  2. 2.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Drivers
  3. 2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Opportunities and Challenges
  4. 2.4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Restraints
3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Manufacturers
  1. 3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Manufacturers, Product Type & Application
  7. 3.7 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Tier 1, Tier 2, and Tier 3
4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Type
  1. 4.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Type Introduction
  2. 4.1.1 PST-900
  3. 4.1.2 NNI-351
  4. 4.1.3 FX-9847
  5. 4.1.4 Others
  6. 4.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type
  7. 4.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021-2032)
  9. 4.2.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2021-2032)
  10. 4.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type
  11. 4.3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2021-2032)
  13. 4.3.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2021-2032)
5 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Application
  1. 5.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Application Introduction
  2. 5.1.1 Pancreatic Cancer
  3. 5.1.2 Down Syndrome
  4. 5.1.3 Colon Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application
  8. 5.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021-2032)
  10. 5.2.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2021-2032)
  11. 5.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application
  12. 5.3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2021-2032)
  14. 5.3.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2021-2032)
6 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region
  1. 6.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2021-2032)
  3. 6.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2021-2026)
  4. 6.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region
  1. 7.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region
  2. 7.1.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2021-2026)
  4. 7.1.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2027-2032)
  5. 7.1.4 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032)
  8. 7.2.2 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032)
  11. 7.3.2 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Carna Biosciences Inc
  2. 8.1.1 Carna Biosciences Inc Company Information
  3. 8.1.2 Carna Biosciences Inc Business Overview
  4. 8.1.3 Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  6. 8.1.5 Carna Biosciences Inc Recent Developments
  7. 8.2 Felicitex Therapeutics
  8. 8.2.1 Felicitex Therapeutics Company Information
  9. 8.2.2 Felicitex Therapeutics Business Overview
  10. 8.2.3 Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  12. 8.2.5 Felicitex Therapeutics Recent Developments
  13. 8.3 ManRos Therapeutics
  14. 8.3.1 ManRos Therapeutics Company Information
  15. 8.3.2 ManRos Therapeutics Business Overview
  16. 8.3.3 ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  18. 8.3.5 ManRos Therapeutics Recent Developments
  19. 8.4 NeuroNascent Inc
  20. 8.4.1 NeuroNascent Inc Company Information
  21. 8.4.2 NeuroNascent Inc Business Overview
  22. 8.4.3 NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  24. 8.4.5 NeuroNascent Inc Recent Developments
  25. 8.5 Pharmasum Therapeutics AS
  26. 8.5.1 Pharmasum Therapeutics AS Company Information
  27. 8.5.2 Pharmasum Therapeutics AS Business Overview
  28. 8.5.3 Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  30. 8.5.5 Pharmasum Therapeutics AS Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Value Chain Analysis
  2. 9.1.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production Mode & Process
  6. 9.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Distributors
  9. 9.2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst